Campbell Bunce

Campbell Bunce, CSO, Abzena, explains their integrated drug development model that combines front-end R&D with process development and manufacturing under one roof.

This article looks at how the MAPPs assay works, how it integrates with other immunogenicity assays, and just how it can be flipped to help in vaccine design.